These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 20521428)
41. [Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy]. Belova LA; Kolotik-Kameneva OIu; Mashin VV; Saprygina LV; Mashin EV Ter Arkh; 2014; 86(9):65-70. PubMed ID: 25518508 [TBL] [Abstract][Full Text] [Related]
42. [EFFECTIVENESS OF CYTOFLAVIN FOR THE CORRECTION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS]. Gatskikh IV; Veselova OF; Brikman IN; Shalda TP; Varygina EL; Kuznetsov MN; Shul'min AV; Petrova MM Eksp Klin Farmakol; 2015; 78(11):21-5. PubMed ID: 27017701 [TBL] [Abstract][Full Text] [Related]
43. [Use of cytoflavin into the complex intensive therapy of acute cerebral insufficiency caused by poisoning]. Vasilyev S; Shilov V; Aleksandrov M; Batotsyrenov B; Loladze A Georgian Med News; 2012 Feb; (203):22-9. PubMed ID: 22466536 [TBL] [Abstract][Full Text] [Related]
44. Early predictive blood markers of hemorrhagic stroke - influence of cytoflavin therapy. Silina EV; Rumyantceva SA; Stupin VA; Parfenov VA; Bolevich SB Can J Physiol Pharmacol; 2021 Jan; 99(1):72-79. PubMed ID: 32910863 [TBL] [Abstract][Full Text] [Related]
45. [Clinical effectiveness of cytoflavin inclusion in intensive care of patients with combined traumatic brain injury]. Lebedeva EA; Kurtasov AA; Belousova ME; Nemkova ZA; Kaminskiĭ MIu; Popov RV; Trofimovich SL Eksp Klin Farmakol; 2014; 77(4):42-4. PubMed ID: 25076759 [TBL] [Abstract][Full Text] [Related]
47. [Dynamics of cognitive disorders in patients with type 2 diabetes mellitus under effect of metabolic therapy]. Gatckikh IV; Petrova MM; Shalda TP; Varygina EL; Kuznetsov MN; Narkevich AN Klin Med (Mosk); 2016; 94(7):533-9. PubMed ID: 30289219 [TBL] [Abstract][Full Text] [Related]
48. [Dynamics of the symptoms of chronic ischemia during the treatment with cytoflavin]. Madzhidova EN; Usmanova DD; Baĭtursunova ZhM Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(9):57-62. PubMed ID: 23235414 [TBL] [Abstract][Full Text] [Related]
49. [The structure of psychopathology associated with addictive disorders, against alcohol addiction and the possibility of it's neurometabolic correction in the elderly]. Belov VG; Parfenov IuA; Zaplutanov VA; Khaĭrutdinov DR Adv Gerontol; 2013; 26(4):696-701. PubMed ID: 24738262 [TBL] [Abstract][Full Text] [Related]
50. [Efficacy of cytoflavin in patients with hypertonic encephalopathy and constitutional venous insufficiency]. Belova LA; Mashin VV; Kolotik-Kameneva OIu; Belova NV; Byrina AV; Evstigneeva AIu; Abramova VV Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(8):21-6. PubMed ID: 23096033 [TBL] [Abstract][Full Text] [Related]
51. [Modern methods of energy homeostasis correction in elderly patients]. Rumiantseva SA; Silina EV; Tsukurova LA; Stupin VA; Chichanovskaia LV; Nazarov MV; Kovalenko AL; Kabaeva EN Adv Gerontol; 2014; 27(4):746-52. PubMed ID: 25946854 [TBL] [Abstract][Full Text] [Related]
52. [Clinical and morphologic efficacy of a complex antioxidant and energy correction therapy of different duration in brain infarction: results of a multicenter randomized trial]. Rumyantsevа SA; Kovalenko AL; Silinа EV; Stupin VA; Kabaeva EN; Chichanovskaya LV; Nazarov MV; Tsukurova LA; Burenichev DV; Golikov KV; Salnikov MV; Belova LA; Mashin VV; Mazina NK; Zhilina EA; Kolotik-Kameneva OY; Sherman MA Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(8):45-52. PubMed ID: 26356615 [TBL] [Abstract][Full Text] [Related]
53. [Behavioral psychotherapy and citoftavin in the treatment of deforming coxarthrosis in elderly patients]. Zakharov KI; Parfyenov SA; Belov VG; Parfyenov UA; Ershov EV; Sapozhnikov KV; Kovalenko AL; Haritonova TV; Skripko VD Adv Gerontol; 2016; 29(5):816-821. PubMed ID: 28556655 [TBL] [Abstract][Full Text] [Related]
54. [Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Mikhaloĭko IIa; Sabadosh RV; Kovalenko AL; Skripko VD Khirurgiia (Mosk); 2014; (12):36-40. PubMed ID: 25589316 [TBL] [Abstract][Full Text] [Related]
55. [Efficacy of cytoflavin in the treatment of burns patients with toxic and post-hypoxic encephalopathy]. Pochepen' ON Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(10):23-9. PubMed ID: 21183910 [TBL] [Abstract][Full Text] [Related]
56. [Current approaches to cerebroprotective treatment of premature newborns in reanimation and intensive care departments]. Rogatkin SO; Volodin NN; Degtiareva MG; Grebennikova OV; Marganiia MSh; Serova ND Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(1):27-32. PubMed ID: 21350408 [TBL] [Abstract][Full Text] [Related]
57. [The intraoperative prophylaxis of local ischemical brain damage in neurosurgical patients with cerebral aneurysm]. Savvina IA; Cherebillo VY; Zabrodskaya YM; Petrova AO; Sergeev AV; Paltsev AA; Rutkovskiy RV; Malkhozova AM Khirurgiia (Mosk); 2019; (5):57-63. PubMed ID: 31169820 [TBL] [Abstract][Full Text] [Related]
58. [Violations of higher mental functions and their correction in patients undergoing video laparoscopic cholecystectomy under conditions of inhalation anesthesia with sevoflurane]. Neymark MI; Shmelev VV; Rakhmonov AA Khirurgiia (Mosk); 2020; (8):69-74. PubMed ID: 32869618 [TBL] [Abstract][Full Text] [Related]